Described herein are methods and kits for prognosis of prostate cancer in a subject. The methods comprises: (a) determining the ratio of PCA3 and PSA expression in a urine sample and (b) correlating the value of the PCA3/PSA ratio with the aggressiveness and mortality risk of prostate cancer in the subject....http://www.google.es/patents/US7960109?utm_source=gb-gplus-sharePatente US7960109 - mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer
mRNA ratios in urinary sediments and/or urine as a prognostic and/or ...
